For in vitro diagnostic use. Others Elecsys AMH Plus IVD Elecsys® AMH Plus CPS_000433 10 059 524 190 10059524190 AMH plus Elecsys E2G 100 V3 Elecsys AMH Plus 07613336226483 Reagents, kits 100 tests cobas e 402/801 true 10 059 516 190 10059516190 AMH plus Elecsys cobas e 100 V3 Elecsys AMH Plus 07613336226476 Reagents, kits 100 tests cobas e 411/601/602 true 10059524500 Elecsys AMH Plus en 2 FF00000006A2CF0E FF0000000636BB0E 10059524190 10059524214 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve, for the prediction of response to controlled ovarian stimulation (COS), to identify polycystic ovarian morphology (PCOM) as an aid in polycystic ovary syndrome (PCOS) diagnosis, and as an aid in diagnosis of Differences of Sex Development (DSD), in conjunction with other clinical and laboratory findings. In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program. Please note that the Elecsys AMH Plus test is not intended to identify patients for treatment with follitropin delta (non-companion diagnostic).The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 10059516500 Elecsys AMH Plus en 2 FF00000006A4680E FF0000000653600E 10059516190 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of anti‑Müllerian hormone (AMH) in human serum and plasma. The determination of AMH is used for the assessment of the ovarian reserve, for the prediction of response to controlled ovarian stimulation (COS), to identify polycystic ovarian morphology (PCOM) as an aid in polycystic ovary syndrome (PCOS) diagnosis, and as an aid in diagnosis of Differences of Sex Development (DSD), in conjunction with other clinical and laboratory findings. In addition, the determination of AMH (in pmol/L) in combination with body weight is used for the establishment of the individual daily dose of the human recombinant follicle-stimulating hormone (rFSH) follitropin delta (in accordance with the current prescribing information of the Ferring follitropin delta) in controlled ovarian stimulation for the development of multiple follicles in women undergoing an assisted reproductive technology program. Please note that the Elecsys AMH Plus test is not intended to identify patients for treatment with follitropin delta (non-companion diagnostic).The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

User profile

Select your user profile

Elecsys^® AMH Plus

Overview

Ordering information

Technical documents

Compatible products

Related products

Contact us